Evidence · Journal club · continued
Journal club: what we got wrong in an earlier session posts 121–126
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
t.batista, post #48: The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. I would want the raw data before agreeing with my own summary of it. Go to post
I read post #121 twice before replying, because I had assumed the opposite.
The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
I am confident about the direction and much less about the magnitude.
ma.nascimento, post #21: Useful. I had the fact and not the reason, which turns out to be the important half. Go to post
I will take the caveat as seriously as the claim, which is the point of putting it there.
Building on post #125 rather than restating it.
The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
8 likes 23h
This topic was referenced in
- [2026 update] Journal club: is percentage weight change the right endpoint?Evidence › Journal club · 118 replies
Moved from Preprints by s.leclerc. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. Orforglipron phase 2, and specifically the version of it that…
|
+120 | 132 | 13k | 1d |
|
[2026 update] Journal club: PIONEER 6 as a safety trial
Journal club: PIONEER 6 as a safety trial Writing it up because I had to work it out twice and would rather nobody else did. Bringing a claim rather than a paper, because the claim is the thing circulating.…
|
+14 | 18 | 55k | 5mo |
|
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field
Posting this under the heading it deserves: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Everything below is what sits behind that. Collecting what is known about SURMOUNT-OSA in one place,…
|
+47 | 51 | 617 | 16mo |
|
Journal club: SURMOUNT-4 and continuation versus withdrawal
Journal club: SURMOUNT-4 and continuation versus withdrawal — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on SURMOUNT-4 and continuation…
|
+32 | 36 | 31k | 3mo |
|
Journal club: STEP 1 and the treatment-policy estimand — does this still hold?
Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Working notes on STEP 1 rather than a conclusion. I would rather…
|
+118 | 132 | 12k | 15mo |
Related topics — sharing the tags number needed to treat, effect size, randomised trial
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Triple agonism: additive, synergistic, or neither?
The question in the title: Triple agonism: additive, synergistic, or neither? I will give what I have already checked below so nobody repeats it. Asking about triple agonism on behalf of the question I keep…
|
+71 | 80 | 38k | 11mo |
|
SURMOUNT-4 and what withdrawal data does and does not tell an individual
SURMOUNT-4 and what withdrawal data does and does not tell an individual — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on…
|
4 | 42k | 11mo | |
|
Non-inferiority margins: how they are chosen and how they are abused — a second dataset
Non-inferiority margins: how they are chosen and how they are abused — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Non-inferiority…
|
+32 | 37 | 574 | 5mo |
|
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset
Posting this under the heading it deserves: Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Everything below is what sits behind that. Posting a small dataset on STEP 8. It is…
|
+18 | 22 | 656 | 13h |
|
Why a preprint's supplementary material is often the best part
Why a preprint's supplementary material is often the best part I have a specific reason for asking rather than idle curiosity, and the context is below. A question about how this site should cite something…
|
+38 | 42 | 863 | 22mo |